Expect Less Concern Over Psychiatric Effects With Champix and Zyban

February 2017

You'll see less concern about psychiatric events with Champix (varenicline) or Zyban (bupropion SR) for smoking cessation.

Warnings about mood changes, agitation, nightmares, and other psychiatric risks are based on case reports.

Now a large trial suggests that these meds do NOT increase those side effects in patients quitting smoking.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice Watch for Situations That Need Pharmacist Involvement to Keep Patients Safe
Interactions Keep Patients Safe From Risky Drug Interactions
Antihistamines Expect to See Blexten and Rupall Rxs for Patients With Allergies
Anticoagulants Be Ready to Handle Rxs for the New Anticoagulant Lixiana
Side Effects Address Taste Disturbances to Prevent Med Adherence Issues
Nasal Sprays Think of OTC Flonase Allergy Relief as Similar to Nasacort Allergy 24HR
Muscle Relaxants Watch for Patients Getting Muscle Relaxants for Acute Low Back Pain Long-Term
Interactions Watch for Statin Interactions With Pradaxa
COPD Be Prepared to Dispense New Inhaler Combos for COPD
Hypotension Understand How Meds to Treat Orthostatic Hypotension Stack Up
Smoking Cessation Expect Less Concern Over Psychiatric Effects With Champix and Zyban
NSAIDs Feel Comfortable Dispensing NSAIDs After Most Fractures